ESC 365 - Anticoagulant should be prescribed for Atrial fibrillation in stage IV-V kidney disease.

EHRA Premium Access

Anticoagulant should be prescribed for Atrial fibrillation in stage IV-V kidney disease.

Session: Anticoagulation for non-valvular atrial fibrillation in 2017

Topic: Anticoagulation

Speaker: Associate Professor M. Chelu (Houston, US)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Mihail Chelu

Baylor College of Medicine, Houston (United States of America)

3 presentations

0 follower

3 more presentations in this session

What is the correct definition of “non-valvular” atrial fibrillation?

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Permanent atrial fibrillation with CHADS-VASC score= 1: nothing, aspirin or anticoagulate?

Speaker: Professor A. Niessner (Vienna, AT)

Anticoagulant should NOT be prescribed for Atrial fibrillation in stage IV-V kidney disease.

Speaker: Doctor A. Natale (Austin, US)

Access the full session

Anticoagulation for non-valvular atrial fibrillation in 2017

Speakers: Associate Professor M. Chelu, Associate Professor T. Potpara, Professor A. Niessner, Doctor A. Natale

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources